Stock Track | Evolent Health Soars 7.19% Pre-Market on Positive Analyst Ratings and Price Target Hike

Stock Track

May 09, 2025

Evolent Health (EVH) shares are soaring 7.19% in pre-market trading on Friday, as the company receives positive attention from Wall Street analysts. The healthcare technology firm's stock is gaining momentum following upbeat analyst reports and a price target increase.

UBS analyst Kevin Caliendo has raised the firm's price target on Evolent Health to $15 from $14, while maintaining a Buy rating on the shares. This upgrade represents increased confidence in the company's growth prospects and potential for value creation.

Additionally, TD Cowen analyst Charles Rhyee reaffirmed a Buy rating on Evolent Health, setting a price target of $14.00. The consistent positive sentiment from multiple analysts is likely contributing to investor enthusiasm and driving the stock's pre-market surge.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1111416830"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111416830\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111416830?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111416830","market":"hk","top_or_hot":-1,"title":"Stock Track | Evolent Health Soars 7.19% Pre-Market on Positive Analyst Ratings and Price Target Hike","media":"Stock Track","content":"<p>Evolent Health (EVH) shares are soaring 7.19% in pre-market trading on Friday, as the company receives positive attention from Wall Street analysts. The healthcare technology firm's stock is gaining momentum following upbeat analyst reports and a price target increase.</p>\n\n<p>UBS analyst Kevin Caliendo has raised the firm's price target on Evolent Health to $15 from $14, while maintaining a Buy rating on the shares. This upgrade represents increased confidence in the company's growth prospects and potential for value creation.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee reaffirmed a Buy rating on Evolent Health, setting a price target of $14.00. The consistent positive sentiment from multiple analysts is likely contributing to investor enthusiasm and driving the stock's pre-market surge.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Evolent Health Soars 7.19% Pre-Market on Positive Analyst Ratings and Price Target Hike</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Evolent Health Soars 7.19% Pre-Market on Positive Analyst Ratings and Price Target Hike\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-09 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Evolent Health (EVH) shares are soaring 7.19% in pre-market trading on Friday, as the company receives positive attention from Wall Street analysts. The healthcare technology firm's stock is gaining momentum following upbeat analyst reports and a price target increase.</p>\n\n<p>UBS analyst Kevin Caliendo has raised the firm's price target on Evolent Health to $15 from $14, while maintaining a Buy rating on the shares. This upgrade represents increased confidence in the company's growth prospects and potential for value creation.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee reaffirmed a Buy rating on Evolent Health, setting a price target of $14.00. The consistent positive sentiment from multiple analysts is likely contributing to investor enthusiasm and driving the stock's pre-market surge.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVH","symbol_name":"Evolent Health Inc","start_time":0,"source_url":"","article_id":"1111416830","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111416830","pubTimestamp":1746797706,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Evolent Health  shares are soaring 7.19% in pre-market trading on Friday, as the company receives positive attention from Wall Street analysts. The healthcare technology firm's stock is gaining momentum following upbeat analyst reports and a price target increase.UBS analyst Kevin Caliendo has raised the firm's price target on Evolent Health to $15 from $14, while maintaining a Buy rating on the shares. This upgrade represents increased confidence in the company's growth prospects and potential ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVH":"Evolent Health Inc"},"translate_title":"由于分析师积极评级和目标价上调，Evolent Health盘前飙升7.19%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVH":1},"content_text":"Evolent Health (EVH) shares are soaring 7.19% in pre-market trading on Friday, as the company receives positive attention from Wall Street analysts. The healthcare technology firm's stock is gaining momentum following upbeat analyst reports and a price target increase.\nUBS analyst Kevin Caliendo has raised the firm's price target on Evolent Health to $15 from $14, while maintaining a Buy rating on the shares. This upgrade represents increased confidence in the company's growth prospects and potential for value creation.\nAdditionally, TD Cowen analyst Charles Rhyee reaffirmed a Buy rating on Evolent Health, setting a price target of $14.00. The consistent positive sentiment from multiple analysts is likely contributing to investor enthusiasm and driving the stock's pre-market surge.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}